126 related articles for article (PubMed ID: 11757706)
1. Therapeutic consequences of pathology and prognostic factors in aggressive NHL--analysis of ALCL.
Gascoyne RD
Ann Hematol; 2001; 80 Suppl 3():B45-8. PubMed ID: 11757706
[No Abstract] [Full Text] [Related]
2. Mediastinal B-cell lymphoma, a lymphoma type with several characteristics unique among diffuse large B-cell lymphomas.
Barth TF; Leithäuser F; Möller P
Ann Hematol; 2001; 80 Suppl 3():B49-53. PubMed ID: 11757707
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in aggressive lymphoma: the contribution of novel biological markers.
Montserrat E
Ann Hematol; 2001; 80 Suppl 3():B42-4. PubMed ID: 11757705
[No Abstract] [Full Text] [Related]
4. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
[TBL] [Abstract][Full Text] [Related]
5. Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms.
Sarris AH; Luthra R; Cabanillas F; Morris SW; Pugh WC
Leuk Lymphoma; 1998 May; 29(5-6):507-14. PubMed ID: 9643564
[TBL] [Abstract][Full Text] [Related]
6. Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project.
Weisenburger DD; Anderson JR; Diebold J; Gascoyne RD; MacLennan KA; Müller-Hermelink HK; Nathwani BN; Ullrich F; Armitage JO
Am J Hematol; 2001 Jul; 67(3):172-8. PubMed ID: 11391714
[TBL] [Abstract][Full Text] [Related]
7. Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma.
Tamaru J; Tokuhira M; Nittsu N; Nakamura S; Ichinohasama R; Suzuki R; Mori H; Takagi T; Suzuki T; Itami J; Itoyama S; Mikata A
Leuk Lymphoma; 2007 Jun; 48(6):1127-38. PubMed ID: 17577776
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic Large Cell Lymphoma.
Medeiros LJ; Elenitoba-Johnson KS
Am J Clin Pathol; 2007 May; 127(5):707-22. PubMed ID: 17511113
[TBL] [Abstract][Full Text] [Related]
9. Pathologic prognostic factors in diffuse aggressive non-Hodgkin's lymphoma.
Gascoyne RD
Hematol Oncol Clin North Am; 1997 Oct; 11(5):847-62. PubMed ID: 9336718
[TBL] [Abstract][Full Text] [Related]
10. [Aggressive lymphomas: a convenient concept or an anatomo-pathological reality?].
Pileri SA; Fraternali-Orcioni G; Ascani S; Piccioli M; Poggi S; Piccaluga PP; Leoncini L; Falini B
Pathologica; 2000 Jun; 92(3):145-61. PubMed ID: 10902425
[No Abstract] [Full Text] [Related]
11. Extranodal non-Hodgkin's lymphomas--a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin's lymphomas.
Lal A; Bhurgri Y; Vaziri I; Rizvi NB; Sadaf A; Sartajuddin S; Islam M; Kumar P; Adil S; Kakepoto GN; Masood N; Khurshed M; Alidina A
Asian Pac J Cancer Prev; 2008; 9(3):453-8. PubMed ID: 19004134
[TBL] [Abstract][Full Text] [Related]
12. Current concepts in cancer: non-Hodgkin's lymphoma--selection of treatment on the basis of histologic type.
Rosenberg SA
N Engl J Med; 1979 Oct; 301(17):924-8. PubMed ID: 384253
[No Abstract] [Full Text] [Related]
13. Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases.
Jones SE; Fuks Z; Bull M; Kadin ME; Dorfman RF; Kaplan HS; Rosenberg SA; Kim H
Cancer; 1973 Apr; 31(4):806-23. PubMed ID: 4574662
[No Abstract] [Full Text] [Related]
14. Multivariate analysis of prognostic factors in the non-Hodgkin's malignant lymphomas.
Bloomfield CD; Goldman A; Dick F; Brunning RD; Kennedy BJ
Cancer; 1974 Mar; 33(3):870-9. PubMed ID: 4592906
[No Abstract] [Full Text] [Related]
15. Non-Hodgkin's lymphoma: the old and the new.
Cabanillas F
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S87-90. PubMed ID: 22035756
[TBL] [Abstract][Full Text] [Related]
16. Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression.
Nakamura S; Shiota M; Nakagawa A; Yatabe Y; Kojima M; Motoori T; Suzuki R; Kagami Y; Ogura M; Morishima Y; Mizoguchi Y; Okamoto M; Seto M; Koshikawa T; Mori S; Suchi T
Am J Surg Pathol; 1997 Dec; 21(12):1420-32. PubMed ID: 9414185
[TBL] [Abstract][Full Text] [Related]
17. 2. Report on the workshop: "Clinical consequences of pathology and prognostic factors in aggressive NHL".
Loeffler M; Shipp M; Stein H
Ann Hematol; 2001; 80 Suppl 3():B8-12. PubMed ID: 11757715
[No Abstract] [Full Text] [Related]
18. ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified.
ten Berge RL; de Bruin PC; Oudejans JJ; Ossenkoppele GJ; van der Valk P; Meijer CJ
Histopathology; 2003 Nov; 43(5):462-9. PubMed ID: 14636272
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's lymphoma.
Lenner P
N Engl J Med; 1980 Mar; 302(11):635. PubMed ID: 6986023
[No Abstract] [Full Text] [Related]
20. Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma.
Wang Y; Wu Y; Miao X; Zhu X; Miao X; He Y; Zhong F; Ding L; Liu J; Tang J; Huang Y; Xu X; He S
Int J Biol Macromol; 2015 Nov; 81():809-17. PubMed ID: 26341817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
